HIV gene therapy shows promise in Phase II
This article was originally published in Scrip
Executive Summary
The first Phase II gene therapy trial for treating HIV has shown some positive results, despite failing to meet its primary endpoint, according to a study by the University of California, Los Angeles, published online in the journal Nature Medicine on February 15th.